Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 3, pp. 812-821
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 13, 2019
- Revision received October 11, 2019
- Accepted December 13, 2019
- Published first December 23, 2019.
Article Versions
- Previous version (December 23, 2019 - 07:23).
- Previous version (February 20, 2020 - 07:23).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Zeliang Zheng1,
- Ryuhei Okada2,
- Hisataka Kobayashi2,
- Tadanobu Nagaya2,
- Junxia Wei1,
- Qi Zhou1,
- Fred Lee1,
- Tapan K. Bera1,
- Yun Gao3,
- William Kuhlman3,
- Chin-Hsien Tai1, and
- Ira Pastan1,*
- 1Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
- 2Laboratory of Molecular Theranostics, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
- 3Selecta Biosciences, Watertown, Massachusetts.
- ↵*Corresponding Author:
Ira Pastan, Laboratory of Molecular Biology, National Cancer Institute, 37 Convent Drive, Room 5106, Bethesda, MD 20892-4264. Phone: 240-760-6470; Fax: 240-541-4501; E-mail: pastani{at}mail.nih.gov
March 2020
Volume 19, Issue 3
Volume 19, Issue 3
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity
Jump to section
Advertisement